Latest Regulatory Milestones News

Echo IQ’s application for a Category III CPT code was declined by the AMA, but the company is exploring reconsideration and new AI-specific coding frameworks to advance US reimbursement.

Emu NL has lifted its trading suspension following the appointment of a new director, meeting regulatory requirements and restoring market confidence.

MAC Copper Limited has outlined the final timetable for its acquisition by Harmony Gold, including key dates for court approval, trading suspension, and shareholder payments.

The U.S. FDA has lifted the clinical hold on Neurizon Therapeutics’ lead drug candidate NUZ-001, enabling its entry into a major ALS platform trial set for Q4 2025. This regulatory milestone accelerates the company’s clinical development and opens doors for broader neurodegenerative applications.

Aguia Resources has enhanced its capital raising by increasing free attaching options to one per new share in its $4 million entitlement issue, now open to shareholders in Australia, New Zealand, and Hong Kong.

Meteoric Resources has obtained crucial environmental consent to operate within the sensitive buffer zone of the Serra da Pedra Branca sanctuary, clearing a major hurdle for its Caldeira Rare Earth Project in Brazil.

Invex Therapeutics has ended negotiations on two neurological asset acquisitions following due diligence setbacks and shareholder disputes, while advancing R&D collaborations and managing financial stability.

Locksley Resources has gained critical regulatory approval and secured contractors to advance its Mojave Project, accelerating exploration of antimony and rare earth elements in California.

Echo IQ reports a remarkable 153% increase in echocardiogram processing through its EchoSolv AS platform in the US, with a Mayo Clinic validation study nearing completion ahead of a critical FDA submission. The company is also advancing European market entry and strengthening its advisory team to accelerate global growth.

Global Uranium and Enrichment Limited reports promising drilling outcomes and regulatory progress at its Pine Ridge Uranium Project in Wyoming, reinforcing its potential amid a strengthening uranium market.

Nova Eye Medical has gained regulatory approval for its iTrack Advance glaucoma device in China, setting the stage for significant market expansion and sales growth from late fiscal 2026.

Orthocell has appointed its first Canadian distributor for Remplir, its innovative nerve repair device, ahead of an official launch at a major surgical conference in Vancouver. The move marks a significant step in expanding the product’s international footprint.